TBK1-PAK1IP1-PAK1 signaling pathway analysis

Exploratory Score: 0.900 Price: $0.50 atherosclerosis endothelial cells Status: proposed

What This Experiment Tests

Exploratory experiment designed to discover new patterns targeting TBK1, PAK1IP1, PAK1 in endothelial cells. Primary outcome: mechanism of TBK1-mediated EndMT signaling

Description

Investigation of the molecular mechanism by which TBK1 drives endothelial-to-mesenchymal transition through its interaction with PAK1IP1 and subsequent effects on PAK1 and ERK1/2 phosphorylation. The study demonstrated that activated TBK1 binds to PAK1IP1, preventing PAK1IP1 from binding to PAK1, which results in increased phosphorylation of PAK1 and ERK1/2 in endothelial cells. This signaling cascade was shown to be a key driver of the EndMT process in atherosclerosis.

TARGET GENE
TBK1, PAK1IP1, PAK1
MODEL SYSTEM
endothelial cells
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
PAK1-ERK1/2 signaling, endothelial-to-mesenchymal transition
SOURCE
extracted_from_pmid_41685426
PRIMARY OUTCOME
mechanism of TBK1-mediated EndMT signaling

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.900 composite

📖 Wiki Pages

TBK1 Autophagy and Neuroinflammation ALS/FTD CausamechanismTBK1 Protein (TANK-Binding Kinase 1)proteinPAK1 GenegeneTBK1-Mediated Neuroinflammation Hypothesis — ImpaimechanismERK1 ProteinproteinTBK1 ProteinproteinERK1 ProteinproteinTBK1 GenegeneTBK1 — TANK Binding Kinase 1genePAK1 ProteinproteinERK1 ProteinredirectTBK1-Mediated Neuroinflammation Hypothesis — AutophypothesisERK1 (MAPK3) — Extracellular Signal-Regulated KinageneEndothelial CellscellcGAS-STING Pathway Inhibition for Chronic Neuroinfidea

Protocol

Protocol: TBK1-PAK1IP1-PAK1 Signaling Pathway Analysis in Endothelial Cells

Study Design


Molecular study to characterize the TBK1-PAK1IP1-PAK1 signaling axis in endothelial cells. Investigate how TBK1 phosphorylation affects PAK1 inhibition by PAK1IP1 and downstream effects on cytoskeletal dynamics.

Cell Culture and Treatment

  • Human aortic endothelial cells (HAOECs) or HUVECs
  • Culture in EBM-2 + EGM-2 MV supplements
  • Serum-starve (0.5% FBS) overnight before treatments
  • Treatments:
    • TBK1 agonist/activator (BTK inhibitor ibrutinib, 1 µM) or TBK1-specific agonist
    • TBK1 siRNA or CRISPR knockout
    • PAK1 activator (PTU, 50 µM) or PAK1 inhibitor (IPA-3, 5 µM)
    • PAK1IP1 overexpression plasmid or siRNA

    ...

    Expected Outcomes

    Expected Outcomes

    Primary Outcomes

  • TBK1-PAK1IP1 interaction: Co-immunoprecipitation confirms physical interaction
  • PAK1IP1 as TBK1 substrate: In vitro kinase assay shows phosphorylation
  • Inverse correlation: TBK1 activation → decreased PAK1IP1 levels, increased PAK1 activity
  • Phenotypic consequence: TBK1 activation promotes stress fibers and migration
  • Secondary Outcomes

    • PAK1IP1 degradation via proteasome (MG132 treatment stabilizes PAK1IP1)
    • Cross-talk with AKT and ERK pathways
    • Integrin signaling involvement (FAK phosphorylation)

    ...

    Success Criteria

    Success Criteria

    Primary

    • [ ] Co-IP: TBK1-PAK1IP1 interaction confirmed in both directions
    • [ ] TBK1 phosphorylates PAK1IP1 in vitro (kinase assay positive)
    • [ ] TBK1 activation: PAK1IP1 protein reduced, PAK1 activity increased
    • [ ] TBK1 knockdown: PAK1IP1 accumulates, PAK1 activity decreases
    • [ ] Phenotype rescue: PAK1IP1 knockdown restores migration in TBK1-KD cells

    Secondary

    • [ ] Time course: peak PAK1IP1 phosphorylation at 30-60 min
    • [ ] Proteasome inhibition: MG132 stabilizes PAK1IP1
    • [ ] Signaling cross-talk documented (AKT, ERK)

    ...

    Related Hypotheses (1)

    TBK1 Loss-of-Function Amplifies C1q-Mediated Synapse Elimination Through Type I IFN Hyperactivation0.724

    Debate History (0)

    No debates yet

    Experiment Results (0)

    No results recorded yet. Use POST /api/experiments/{id}/results to record a result.